CIK: 1606030 - Address: C/O Repligen Corporation, 41 Seyon St., Bldg 1, Ste 100, Waltham, MA 02453
26 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret111-4-4-6-400-5
S%wins100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/22/24 16:52
11/21/24
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADS.d-3,386139.670-24-15140D
9/12/24 11:35
9/10/24
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADS.d-3,226145.370-22-14140D
5/22/24 17:14
5/21/24
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMAOCEOS-3,377168.260-20-11163D
3/11/24 19:43
3/8/24
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMAOCEOS.d-3,299197.440-17-8185D
11/14/22 17:43
11/11/22
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-5,000200.000-25-12178D
9/9/22 16:14
9/8/22
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-5,933224.730-26-13178D
7/22/22 16:25
7/21/22
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-4,960200.000-25-11195D
11/19/21 16:45
11/18/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-4,805276.850-17-9182D
9/13/21 18:24
9/9/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-7,369294.750-25-12189D
5/20/21 21:00
5/19/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS-3,817171.410-22-10190D
3/12/21 19:34
3/12/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS-1,733190.380-9-4213D
3/8/21 21:51
3/4/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS-4,165190.190-22-9222D
11/23/20 19:03
11/19/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-3,716185.800-20-8233D
9/14/20 07:43
9/10/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-6,721148.200-45-16233D
5/26/20 21:27
5/21/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-6,562139.770-47-17233D
3/5/20 17:50
3/3/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.m-1,30289.840-14-6230D
2/27/20 17:39
2/25/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.dm-1,37590.410-15-6226D
9/23/19 18:02
9/19/19
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-29882.890-4-2219D
9/11/19 16:58
9/9/19
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS-99782.400-12-6203D
3/20/19 08:20
3/18/19
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS-86859.630-15-6215D
3/5/19 17:35
3/5/19
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS-76158.500-13-5230D
3/4/19 18:52
2/28/19
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-44159.010-7-3243D
9/12/18 16:15
9/10/18
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS.d-1,59157.710-28-11227D
5/22/18 17:12
5/21/18
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS-69142.530-16-6243D
1/24/18 17:04
1/22/18
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMADOCEOS-32235.950-9-1084D
11/29/16 16:58
11/28/16
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagHunt AnthonyMAOCEOS-16633.1210-5-768D4214386142033-4-4-6-4

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact